The host response to invasion by Streptococcus pneumoniae: protection and the pathogenesis to tissue damage.

PubWeight™: 1.35‹?› | Rank: Top 10%

🔗 View Article (PMID 7020045)

Published in Rev Infect Dis on September 25, 1981

Authors

R B Johnston

Articles by these authors

(truncated to the top 100)

Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85

The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J Clin Invest (1975) 7.40

Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 7.17

Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med (1978) 6.50

Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol (1985) 5.02

The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors. J Exp Med (1969) 4.96

Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med (1984) 3.79

Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood (1976) 3.34

Generation of superoxide anion and chemiluminescence by human monocytes during phagocytosis and on contact with surface-bound immunoglobulin G. J Exp Med (1976) 3.19

Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J Exp Med (1980) 3.13

An abnormality of the alternate pathway of complement activation in sickle-cell disease. N Engl J Med (1973) 3.11

Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J Exp Med (1980) 2.96

Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J Clin Invest (1987) 2.93

Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest (1970) 2.92

Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease. J Clin Invest (1976) 2.85

Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81

Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system. J Clin Invest (1981) 2.66

Preclinical evaluation of a rheolytic catheter for percutaneous coronary artery/saphenous vein graft thrombectomy. J Invasive Cardiol (1999) 2.66

Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b. J Immunol (1979) 2.47

The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J Clin Invest (1975) 2.40

Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function. Immunopharmacology (1980) 2.35

Inhibition of phagocytosis-associated chemiluminescence by superoxide dismutase. Infect Immun (1974) 2.26

Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest (1986) 2.22

Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response. J Immunol (1982) 2.19

Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N Engl J Med (1970) 2.08

Oxygen metabolism and the microbicidal activity of macrophages. Fed Proc (1978) 2.04

Monocyte function in children with neutropenia and chronic infections. Blood (1972) 1.98

Improvement of leukocyte bactericidal activity in chronic granulomatous disease. Blood (1970) 1.90

Dissociation of phagocytosis from stimulation of the oxidative metabolic burst in macrophages. J Exp Med (1984) 1.85

Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide. J Exp Med (1980) 1.79

Chronic granulomatous disease: correlation between pathogenesis and clinical findings. Pediatrics (1971) 1.76

Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma. J Immunol (1986) 1.74

Stimulation of neutrophil oxidative metabolism by chemotactic peptides: influence of calcium ion concentration and cytochalasin B and comparison with stimulation by phorbol myristate acetate. Blood (1979) 1.71

Characterization of human antibody to polyribophosphate, the capsular antigen of Hemophilus influenzae, type B. Clin Immunol Immunopathol (1973) 1.60

Superoxide dismutase activity in leukocytes. J Clin Invest (1974) 1.59

Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J Immunol (1991) 1.58

Kinetic assessment of alternative complement pathway activity in a hemolytic system. II. Influence of antibody on alternative pathway activation. J Immunol (1978) 1.54

Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst. Role of intracellular free calcium. J Clin Invest (1989) 1.53

Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest (1993) 1.50

S-thiolation of glyceraldehyde-3-phosphate dehydrogenase induced by the phagocytosis-associated respiratory burst in blood monocytes. J Biol Chem (1994) 1.46

Secondary disorders of the complement system. Am J Dis Child (1989) 1.42

Metabolic and bactericidal activities of human eosinophils. Br J Haematol (1971) 1.41

Chronic granulomatous disease. Pediatr Clin North Am (1977) 1.39

An overview of infant mortality and birth defects in the United States. Teratology (1997) 1.38

Tubewell water quality and predictors of contamination in three flood-prone areas in Bangladesh. J Appl Microbiol (2008) 1.37

The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion. J Immunol (1988) 1.33

Immune response to acute otitis media in children. I. Serotypes isolated and serum and middle ear fluid antibody in pneumococcal otitis media. Infect Immun (1974) 1.30

Clinical features and current management of chronic granulomatous disease. Hematol Oncol Clin North Am (1988) 1.28

Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia. N Engl J Med (1970) 1.27

Separation of serum bactericidal and opsonizing activities for Haemophilus influenzae type b. Infect Immun (1973) 1.27

Protein kinase C isotypes and signaling in neutrophils. Differential substrate specificities of a translocatable calcium- and phospholipid-dependent beta-protein kinase C and a phospholipid-dependent protein kinase which is inhibited by long chain fatty acyl coenzyme A. J Biol Chem (1991) 1.26

Complement and host defense against infection. J Pediatr (1977) 1.26

Generation of chemiluminescence by a particulate fraction isolated from human neutrophils. Analysis of molecular events. J Clin Invest (1979) 1.26

Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: studies in a model of tissue-bound IgG. Clin Immunol Immunopathol (1978) 1.26

S-thiolation of individual human neutrophil proteins including actin by stimulation of the respiratory burst: evidence against a role for glutathione disulfide. Arch Biochem Biophys (1994) 1.26

Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease. J Reticuloendothel Soc (1972) 1.25

Molecular basis for the enhanced respiratory burst of activated macrophages. Fed Proc (1985) 1.23

Epidemiologic studies of Streptococcus pneumoniae in infants: antibody response to nasopharyngeal carriage of types 3, 19, and 23. J Infect Dis (1981) 1.21

Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway. N Engl J Med (1978) 1.20

Activity of the alternative complement pathway after splenectomy: comparison to activity in sickle cell disease and hypogammaglobulinemia. J Pediatr (1979) 1.16

D2O-alanine exchange reactions catalyzed by alanine racemase and glutamic pyruvic transminase. Biochem Biophys Res Commun (1974) 1.16

Priming of macrophages for enhanced oxidative metabolism by exposure to proteolytic enzymes. J Exp Med (1981) 1.16

Activation of mouse peritoneal macrophages by lipopolysaccharide alters the kinetic parameters of the superoxide-producing NADPH oxidase. J Biol Chem (1983) 1.15

Chronic familial granulomatosis. Report of five cases and review of the literature. Am J Dis Child (1967) 1.13

Immunoglobulins of the middle ear fluid in acute otitis media: relationship to serum immunoglobulin concentrations and bacterial cultures. Infect Immun (1973) 1.12

Kinetic assessment of alternative complement pathway activity in a hemolytic system. I. Experimental and mathematical analyses. J Immunol (1978) 1.10

The immune response to acute otitis media in children. II. Serum and middle ear fluid antibody in otitis media due to Haemophilus influenza. J Infect Dis (1975) 1.09

Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants. J Immunol (1994) 1.09

Training professionals to record proceedings of interdisciplinary team conferences. Appl Res Ment Retard (1985) 1.07

Deficiency of NADPH oxidase activity in chronic granulomatous disease. J Pediatr (1977) 1.05

Increased susceptibility to infection in sickle cell disease: review of its occurrence and possible causes. South Med J (1974) 1.04

Chronic arthritis after rubella vaccination. Clin Infect Dis (1992) 1.04

Measurement of O2- secreted by monocytes and macrophages. Methods Enzymol (1984) 1.04

Mechanisms of host defense against Candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes. J Immunol (1991) 1.04

Immune response to acute otitis media: association between middle ear fluid antibody and the clearing of clinical infection. J Clin Microbiol (1976) 1.04

Chronic granulomatous disease and Pneumocystis carinii pneumonia. Pediatrics (1982) 1.03

Respiratory burst enzyme in human neutrophils. Evidence for multiple mechanisms of activation. J Clin Invest (1981) 1.03

Functional and biochemical studies of multinucleated giant cells derived from the culture of human monocytes. J Exp Med (1984) 1.02

Injury patterns in recreational rock climbers. Am J Sports Med (1996) 1.02

Enhancement by Ca2+ or Mg2+ of catalytic activity of the superoxide-producing NADPH oxidase in membrane fractions of human neutrophils and monocytes. J Biol Chem (1985) 1.00

Priming of neutrophils and macrophages for enhanced release of superoxide anion by the calcium ionophore ionomycin. Implications for regulation of the respiratory burst. J Biol Chem (1987) 0.99

Reversal of flecainide-induced ventricular arrhythmia by hypertonic sodium bicarbonate in dogs. Am J Emerg Med (1995) 0.97

Activation of the respiratory burst in macrophages. Phosphorylation specifically associated with Fc receptor-mediated stimulation. J Immunol (1988) 0.97

Residual pulmonary findings in clinical hyaline-membrane disease. N Engl J Med (1968) 0.97

Protein S-thiolation and dethiolation during the respiratory burst in human monocytes. A reversible post-translational modification with potential for buffering the effects of oxidant stress. J Immunol (1996) 0.96

Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor. Infect Immun (1998) 0.96

Complement in the newborn infant. Pediatrics (1979) 0.93

Oxidative metabolism of cord blood neutrophils: relationship to content and degranulation of cytoplasmic granules. Pediatr Res (1984) 0.93

Impaired macrophage function in severe protein-energy malnutrition. Arch Surg (1991) 0.93

Oxidative stress induces S-thiolation of specific proteins in cultured gastric mucosal cells. Am J Physiol (1994) 0.93

An unusual form of chronic neutropenia in a father and daughter with hypogammaglobulinaemia. Br J Haematol (1977) 0.92

Infections in patients with neutropenia. Am J Dis Child (1977) 0.91

Hyperoxia enhances expression of gamma-glutamyl transpeptidase and increases protein S-glutathiolation in rat lung. Am J Physiol (1996) 0.91

Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. JAMA (1994) 0.91

Enhanced release of oxygen metabolites by monocyte-derived macrophages exposed to proteolytic enzymes: activity of neutrophil elastase and cathepsin G. J Immunol (1984) 0.91

Increased susceptibility to severe pyogenic infections in patients with an inherited deficiency of the second component of complement. J Pediatr (1981) 0.90

International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy. Br J Cancer (2012) 0.90

Controlled lysis of bacterial cells utilizing mutants with defective synthesis of D-alanine. Can J Microbiol (1988) 0.90

Differences in the ability of human peripheral blood monocytes and in vitro monocyte-derived macrophages to produce superoxide anion: studies with cells from normals and patients with chronic granulomatous disease. J Reticuloendothel Soc (1982) 0.90

The child with frequent infections: diagnostic considerations. Pediatrics (1969) 0.90